Gentronix
Dr Karen Philp joined Gentronix as a Study Director in 2021, primarily responsible for the oversight of Big Blue® OECD 488 studies. Karen has extensive prior experience as a Study Director and her GLP and regulatory writing skills acquired over the last 18 years will be an asset to the future growth of Gentronix.
This person is not in any offices
Gentronix
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.